No Data
No Data
RBC Capital Reiterates Outperform on Caribou Biosciences, Maintains $14 Price Target
Express News | Caribou Biosciences Inc : Leerink Partners Cuts Target Price to $9 From $10
Caribou Bioscience GAAP EPS of -$0.42 Beats by $0.04, Revenue of $3.46M Beats by $0.42M
Caribou Biosciences | 10-Q: Q2 2024 Earnings Report
Press Release: Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
Caribou Biosciences, Inc. (CRBU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
No Data